09.12.2018
Improve Outcomes
$495,966.00
36 months
Glucose Responsive Glucagon - Glucose Stabilized Materials
Development of a novel glucose responsive glucagon therapy that could improve glucose control and reduce the chance of hypoglycemia for people with Type 1 Diabetes.